Significant and modifiable excess mortality due to high-risk pulmonary embolism requires improved risk stratification, rapid translation of reperfusion data, and quality improvement initiatives.
Highlights clinical, research, and policy priorities to address the rising mortality trend in high-risk pulmonary embolism in the US.
BACKGROUND: Deaths from high-risk pulmonary embolism (PE) appear to have increased in the US over the last decade. Modifiable risks contributing to this worrisome trend present opportunities for physicians, researchers, and healthcare policymakers to improve care. METHODS: We sought to contextualize contemporary, high-risk PE epidemiology and examine clinical trials, quality improvement opportunities, and healthcare policy initiatives directed at reducing mortality. RESULTS: We observed significant and modifiable excess mortality due to high-risk PE. We identified several opportunities to improve care including: (1) rapid translation of forthcoming data on reperfusion strategies into clinical practice; (2) improved risk stratification tools; (3) quality improvement initiatives to address presumptive anticoagulation practice gaps; and (3) adoption of health policy initiatives to establish pulmonary embolism response teams and address the social determinants of health. CONCLUSION: Addressing knowledge and practice gaps in intermediate and high-risk PE management must be prioritized and informed by forthcoming high-quality data. Implementation efforts are needed to improve acute PE management and resolve treatment disparities.
Casey et al. (Fri,) conducted a review in High-risk pulmonary embolism. Significant and modifiable excess mortality due to high-risk pulmonary embolism requires improved risk stratification, rapid translation of reperfusion data, and quality improvement initiatives.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: